Tourmaline Bio Inc. (TRML) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $47.98
• Market Cap: $1.23B
• EPS: $-3.44
• 52-Week High: $48.27
• 52-Week Low: $11.56

About Tourmaline Bio Inc.

None

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Tourmaline Bio Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TRML pay dividends?

Tourmaline Bio Inc. (TRML) does not currently pay a regular dividend.

What is TRML's market cap?

Tourmaline Bio Inc. (TRML) has a market capitalization of $1.23B with a current stock price of $47.98.